Merit Medical reports 92.7% six-month target lesion primary patency for WRAPSODY in AVF registry cohort
MMSI•Merit Medical reported 92.7% six-month target lesion primary patency for WRAPSODY in an arteriovenous fistula registry cohort. The registry included 237 patients across 31 sites in nine countries.
1. Registry results
The WRAP Global registry evaluated 237 patients with arteriovenous fistulas across 31 sites in nine countries. Six-month results were presented on Oct. 31, 2026, at the Controversies in Dialysis Access conference in Washington, D.C.
